PlainBillCongress, translated.Legislation. Context. Public interest.
H.R.4743 / 106th Congress

Drug Availability and Health Care Access Improvement Act of 2000

Referred to the Subcommittee on Health and Environment.

Official summary

Version 00 · Introduced in House · Jun 26, 2000

Drug Availability and Health Care Access Improvement Act of 2000 - Title I: Medicaid Prescription Drug Coverage for Low-Income Medicare Beneficiaries - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require State Medicaid plans to cover prescribed drugs for qualified Medicare (SSA title XVIII) and other low-income Medicare beneficiaries. Provides full Federal funding for such Medicaid coverage.Title II: Improved Access of Americans to Health Insurance Coverage - Subtitle A: Access of Medicare Beneficiaries to Medicare+Choice Plans - Amends SSA title XVIII part C (Medicare+Choice) with respect to access to Medicare+Choice plans through an increase in the minimum Medicare+Choice capitation rate.Subtitle B: Access of the Self-Employed - Amends the Internal Revenue Code to provide for a tax deduction for the full amount of health insurance costs of self-employed individuals.Subtitle C: Improve the Coverage of Needy Children under the State Children's Health Insurance Program (SCHIP) and the Medicaid Program - Amends SSA titles XIX and XXI (State Children's Health Insurance Program) (SCHIP) to require the respective State Medicaid and SCHIP plans to provide for eligibility determinations, coordinated enrollment, and response to electronic communications received through the national toll-free system the Secretary shall establish.(Sec. 221) Amends SSA titles XIX and XXI to provide financial incentives to promote outreach and enrollment activities.Amends SSA title XIX to provide for additional entities qualified to determine Medicaid presumptive eligibility for low-income children.(Sec. 222) Amends SSA title XXI with respect to coordination of pediatric care within a family and reduction in the burden of administering cost-sharing provisions under SCHIP.(Sec. 223) Amends SSA title XIX and XXI to provide for automatic reassessment of eligibility for Medicaid and SCHIP benefits in the case of a child who loses eligibility for Medicaid or SCHIP benefits on the basis of changes in income, assets, or age.Amends SSA title XXI to authorize optional coverage of low-income, uninsured pregnant women under a State SCHIP plan.Amends SSA title XIX to give States the option to use an enhanced Federal medical assistance percentage for coverage of additional pregnant women under Medicaid.Amends SSA titles XIX and XXI to give States the option to cover qualified alien children under Medicaid and SCHIP.Amends the Immigration and Nationality Act to except child Medicaid or SCHIP assistance from the prohibition on seeking support from sponsors.Amends SSA title XXI to provide for: (1) elimination of the funding offset for exercise of the presumptive eligibility option under SCHIP; and (2) coordination of it with the Maternal and Child Health Services program under SSA title V.Title III: Improved Access to Reasonably Priced Prescription Drugs - Amends the Federal Food, Drug, and Cosmetic Act with regard to: (1) conditions for Food and Drug Administration (FDA) warning notices about imported drugs; and (2) consumer information in prescription drug advertising.(Sec. 303) Directs the Secretary to inform patients of the existence of programs operated by prescription drug manufacturers to provide such drugs to patients without charge.(Sec. 304) Expresses the sense of the Congress that: (1) the increased merger of drug manufacturers has resulted in a decrease in price competition in the prescription drug market and increased the potential for collusion in setting prices; and (2) the Antitrust Division of the Department of Justice and the Federal Trade Commission should give increased scrutiny to the anti-competitive effects of such mergers.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Rep. Ganske, Greg [R-IA-4] · R–IA

Committees

  • Energy and Commerce Committee
  • Ways and Means Committee
0 cosponsorship records, including any withdrawals

    Actions

    A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

    1. Referred to the Subcommittee on Health and Environment.

    2. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    3. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    4. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    5. Introduced in House

    6. Introduced in House

    Bill text & related measures

    Text links open the official source. We currently store references to these documents.

    Related bills identified by Congress.gov

    No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.

    Source last updated: Jun 3, 2026. Consult Congress.gov for the current record.

    Explore the bill from different angles

    Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

    Neutral evidence review

    Objective

    Analyze H.R.4743 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

    View full prompt & sources
    Fairness and public impact

    Progressive lens

    Examine H.R.4743 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

    View full prompt & sources
    Institutions and government scope

    Conservative lens

    Examine H.R.4743 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

    View full prompt & sources
    Individual rights and government power

    Liberty lens

    Examine H.R.4743 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

    View full prompt & sources